This compound is a fluorinated derivative of prasugrel, used as an intermediate in the synthesis of pharmaceutical products. Its structure includes a thienopyridine ring system and a cyclopropyl carbonyl group.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1391194-39-0
4-Fluoro prasugrel
pharmaceutical intermediate
Prasugrel
platelet aggregation inhibitor
Prasugrel hydrochloride
active pharmaceutical ingredient
Folic Acid EP Impurity F
Folic acid impurity reference standard
4-(2-Hydroxyethyl)indolin-2-one
Pharmaceutical intermediate for indole derivatives
(2R,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-hydroxy-4-phenylbutanoic acid
Peptide synthesis building block
(2R,4S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-(((dimethylamino)methylene)amino)-6-oxo-1H-purin-9(6H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
Nucleoside phosphoramidite building block
(+/-)-Prasugrel-d3 (acetate-d3)
active pharmaceutical ingredient
[5-[2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
IMTFHRNDRHBYGI-UHFFFAOYSA-N
CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC(=CC=C3)F)C(=O)C4CC4